Latest News and Articles

Ultragenyx partners with GeneTx for antisense technology

Ultragenyx partners with GeneTx for antisense technology

FDA ditches Sarepta’s antisense oligonucleotide treatment for DMD

FDA ditches Sarepta’s antisense oligonucleotide treatment for DMD

Lentiviral gene therapy shows clinical benefit in macaque models of Parkinson’s disease

Lentiviral gene therapy shows clinical benefit in macaque models of Parkinson’s disease

Pfizer invests $500 million in new gene therapy facility in Sanford, NC

Pfizer invests $500 million in new gene therapy facility in Sanford, NC


CGTI

CELL & GENE THERAPY INSIGHTS

Senior Editor: Prof. Chris Mason, AVROBIO and UCL, UK
The peer-reviewed, open access publication bringing you the latest research, reviews and updates from across the sector

Read more 


BioInsights – the publisher of Cell & Gene Therapy Insights

– is your content marketing partner for life sciences.

Sponsorship